Literature DB >> 25409838

Treatment of achalasia with laparoscopic myotomy or pneumatic dilatation: long-term results of a prospective, randomized study.

Jan Persson1, Erik Johnsson, Srdjan Kostic, Lars Lundell, Ulrika Smedh.   

Abstract

BACKGROUND: This study compares the long-term results of pneumatic dilatations versus laparoscopic myotomy using treatment failure as the primary outcome. The frequency and degree of dysphagia, the effects on quality of life (QoL), and health economy were also examined.
METHODS: Fifty-three patients with achalasia were randomized to laparoscopic myotomy with a posterior partial fundoplication [laparoscopic myotomy (LM) n = 25] or repetitive pneumatic dilatation [pneumatic dilatation (PD) n = 28]. The median observation period was 81.5 months (range 12-131).
RESULTS: At the minimal follow-up of 5 years, ten patients (36%) in the dilatation group and two patients (8%) in the myotomy group, including two patients lost to follow-up (one in each arm), were classified as failures (p = 0.016). The cumulative incidence of treatment failures was analyzed by survival statistics. Taking the entire follow-up period into account, a significant difference was observed in favor of the LM strategy (p = 0.02). Although both treatments resulted in significant improvements in dysphagia scores, LM was significantly favored over PD after 1 and 3 years, but not after 5 years. Health-related QoL assessed by the personal general well being score was higher in the LM group after 3 years, but the difference was not fully statistically significant at 5 years. Direct medical costs during the entire follow-up period were in median $13,421 for LM as compared to $5,558 for PD (p = 0.001).
CONCLUSIONS: This long-term follow-up of a randomized clinical study shows that LM is superior to repetitive PD treatment of newly diagnosed achalasia, albeit that this surgical strategy is burdened by high initial direct medical costs. www.ClinicalTrials.gov NCT 02086669.

Entities:  

Mesh:

Year:  2015        PMID: 25409838     DOI: 10.1007/s00268-014-2869-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  28 in total

1.  [Technic of esophago-gastroplasty with phrenogastropexy used in radical treatment of hiatal hernias as a supplement to Heller's operation in cardiospasms].

Authors:  A TOUPET
Journal:  Mem Acad Chir (Paris)       Date:  1963 Mar 20-27

2.  Laparoscopic Heller's cardiomyotomy achieved lesser recurrent dysphagia with better quality of life when compared with endoscopic balloon dilatation for treatment of achalasia.

Authors:  S M Chan; P W Y Chiu; J C Y Wu; S M Kwan; P Y Kwong; K W Lam; K K Lo; M K M Tee; C P Wong; A Y B Teoh; S K H Wong; E K W Ng
Journal:  Dis Esophagus       Date:  2012-05-24       Impact factor: 3.429

3.  A new dysphagia score with objective validation.

Authors:  M Dakkak; J R Bennett
Journal:  J Clin Gastroenterol       Date:  1992-03       Impact factor: 3.062

4.  Pneumatic dilatation or laparoscopic cardiomyotomy in the management of newly diagnosed idiopathic achalasia. Results of a randomized controlled trial.

Authors:  S Kostic; A Kjellin; M Ruth; H Lönroth; E Johnsson; M Andersson; L Lundell
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

Review 5.  2011 update on esophageal achalasia.

Authors:  Seng-Kee Chuah; Pin-I Hsu; Keng-Liang Wu; Deng-Chyang Wu; Wei-Chen Tai; Chi-Sin Changchien
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

6.  Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease.

Authors:  E Dimenäs; G Carlsson; H Glise; B Israelsson; I Wiklund
Journal:  Scand J Gastroenterol Suppl       Date:  1996

7.  Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens?

Authors:  E Dimenäs; H Glise; B Hallerbäck; H Hernqvist; J Svedlund; I Wiklund
Journal:  Scand J Gastroenterol       Date:  1993-08       Impact factor: 2.423

Review 8.  Esophageal motility disorder achalasia.

Authors:  Joel E Richter
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2013-12       Impact factor: 2.064

Review 9.  The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry.

Authors:  Peter J Kahrilas; Guy Boeckxstaens
Journal:  Gastroenterology       Date:  2013-08-21       Impact factor: 22.682

10.  Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial.

Authors:  L Lundell; S Attwood; C Ell; R Fiocca; J-P Galmiche; J Hatlebakk; T Lind; O Junghard
Journal:  Gut       Date:  2008-05-09       Impact factor: 23.059

View more
  23 in total

Review 1.  Data analyses and perspectives on laparoscopic surgery for esophageal achalasia.

Authors:  Kazuto Tsuboi; Nobuo Omura; Fumiaki Yano; Masato Hoshino; Se-Ryung Yamamoto; Shunsuke Akimoto; Takahiro Masuda; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

2.  Evaluating the reliability and construct validity of the Eckardt symptom score as a measure of achalasia severity.

Authors:  T H Taft; D A Carlson; J Triggs; J Craft; K Starkey; R Yadlapati; D Gregory; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2018-01-08       Impact factor: 3.598

Review 3.  Safety and efficacy of POEM for treatment of achalasia: a systematic review of the literature.

Authors:  Oscar M Crespin; Louis W C Liu; Ambica Parmar; Timothy D Jackson; Jemila Hamid; Eran Shlomovitz; Allan Okrainec
Journal:  Surg Endosc       Date:  2016-09-15       Impact factor: 4.584

Review 4.  Updated Systematic Review of Achalasia, with a Focus on POEM Therapy.

Authors:  Mitchell S Cappell; Stavros Nicholas Stavropoulos; David Friedel
Journal:  Dig Dis Sci       Date:  2019-08-27       Impact factor: 3.199

5.  POEM vs Laparoscopic Heller Myotomy and Fundoplication: Which Is Now the Gold Standard for Treatment of Achalasia?

Authors:  Marco G Patti; Ciro Andolfi; Steven P Bowers; Nathaniel J Soper
Journal:  J Gastrointest Surg       Date:  2016-11-14       Impact factor: 3.452

Review 6.  Current status of achalasia management: a review on diagnosis and treatment.

Authors:  Joshua Tuason; Haruhiro Inoue
Journal:  J Gastroenterol       Date:  2017-02-10       Impact factor: 7.527

7.  An Overview of Achalasia and Its Subtypes.

Authors:  Dhyanesh A Patel; Brian M Lappas; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-07

8.  Mucosal perforation during laparoscopic surgery for achalasia: impact of preoperative pneumatic balloon dilation.

Authors:  Yoshihito Souma; Kiyokazu Nakajima; Eiji Taniguchi; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Yasuhiro Miyazaki; Tomoki Makino; Tetsuhiro Hamada; Jun Yasuda; Takeyoshi Yumiba; Shuichi Ohashi; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Surg Endosc       Date:  2016-08-08       Impact factor: 4.584

9.  Mucosal Perforation During Laparoscopic Heller Myotomy Has No Influence on Final Treatment Outcome.

Authors:  Renato Salvador; Lorenzo Spadotto; Giovanni Capovilla; Guerrino Voltarel; Elisa Pesenti; Cristina Longo; Francesco Cavallin; Loredana Nicoletti; Alberto Ruol; Michele Valmasoni; Stefano Merigliano; Mario Costantini
Journal:  J Gastrointest Surg       Date:  2016-09-29       Impact factor: 3.452

10.  Pneumatic balloon dilatation versus laparoscopic Heller myotomy for achalasia: a failed attempt at meta-analysis.

Authors:  Jocelyn de Heer; Madhav Desai; Guy Boeckxstaens; Giovanni Zaninotto; Karl-Hermann Fuchs; Prateek Sharma; Guido Schachschal; Oliver Mann; Thomas Rösch; Yuki Werner
Journal:  Surg Endosc       Date:  2020-03-16       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.